Aethlon Medical (AEMD) Reports Q2 Loss of $0.16/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts AEMD Hot Sheet
Price: $5.80 +9.64%
Financial Fact:
Payroll and related: 1.81M
Today's EPS Names:
FUSE, INM, TRI, More
Financial Fact:
Payroll and related: 1.81M
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Aethlon Medical (NASDAQ: AEMD) reported Q2 EPS of ($0.16), versus ($0.16) reported last year. Revenue for the quarter came in at $188 thousand, versus $479.1 thousand reported last year.
For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Ferroglobe (GSM) Misses Q3 EPS by 3c
- Flux Power Holdings, Inc. (FLUX) Misses Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
